Basmisanil – (1159600-41-5)

Basmisanil (RG1662) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors.

It was under development by Roche for the treatment of cognitive impairment associated with Down syndrome.

As of June 2016, it is no longer studied for this purpose. It has also undergone clinical trials for cognitive impairment in patients with schizophrenia.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Basmisanil (RG1662) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors.

It was under development by Roche for the treatment of cognitive impairment associated with Down syndrome.

As of June 2016, it is no longer studied for this purpose. It has also undergone clinical trials for cognitive impairment in patients with schizophrenia.

The above informationis displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
Sources:
https://en.wikipedia.org/wiki/Basmisanil
https://pubchem.ncbi.nlm.nih.gov/compound/57336276
https://www.medchemexpress.com/Basmisanil.html
https://www.medkoo.com/products/7804
https://www.nature.com/articles/s41598-021-87307-7
https://www.sciencedirect.com/science/article/abs/pii/S0304394024002064
Other Names

Basmisanil, Basmisanil [INN], (1, 1-Dioxidothiomorpholino)(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl)methoxy)pyridin-3-yl)methanone, Basmisanil (RG1662)

IUPAC Name

(1, 1-dioxo-1, 4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1, 2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone

CAS

1159600-41-5

Molecular Weight

445.5

Molecular Formula

C21H20FN3O5S

SMILES

CC1=C(C(=NO1)C2=CC=C(C=C2)F)COC3=NC=C(C=C3)C(=O)N4CCS(=O)(=O)CC4

No products in the cart.